Articles related toCardiopulmonary Medicine

Heart Failure With Preserved Ejection Fraction

Felix J. Rogers, DO; Teja Gundala, MD; Jahir E. Ramos, DO; and Asif Serajian, DO
J Osteopath Med; 115(7): 432-442

Age-Related Decline in Chest Wall Mobility: A Cross-Sectional Study Among Community-Dwelling Elderly Women

Daiki Adachi, RPT, BS; Minoru Yamada, PhD; Shu Nishiguchi, RPT, MSc; Naoto Fukutani, RPT, MSc; Takayuki Hotta, RPT, BS; Yuto Tashiro, RPT, BS; Saori Morino, RPT, BS; Hidehiko Shirooka, RPT, BS; Yuma Nozaki, RPT, BS; Hinako Hirata, RPT, BS; Moe Yamaguchi, RPT, BS; and Tomoki Aoyama, MD, PhD
J Osteopath Med; 115(6): 384-389

Spontaneous Pneumomediastinum in a Pediatric Patient After a 1600m Run: Case Report and Literature Review

CPT Zachary C. Booms, DO, and MAJ George A. Barbee, PA-C
J Osteopath Med; 115(5): 338-341

Pulmonary Lymphangitic Carcinomatosis From Metastatic Gastric Adenocarcinoma: Case Report

Arsineh Khachekian, DO; Sean Shargh, DO; and Sarkis Arabian, DO
J Osteopath Med; 115(5): 332-337

Role of Antiplatelet Therapy in Stroke Prevention in Patients With Atrial Fibrillation

Rohini Manaktala, DO, and Jeffrey Kluger, MD
Guidelines from the United States support the use of antiplatelet therapy for stroke prevention in low risk patients with atrial fibrillation. However, the authors of this narrative review propose that it may be time to update those guidelines.
J Osteopath Med; 117(12): 761-771

Pheochromocytoma Induced Cardiomyopathy Mimicking Acute Coronary Syndrome

Viliane Vilcant, MBS, DO
Pheochromocytoma is a rare catecholamine secreting tumor with a prevalence of 0.1% to 0.6% in hypertensive patients. The classic triad of symptoms is headache, palpitations, and diaphoresis, but clinical presentation varies greatly. In the present case, a patient presented to the emergency department with symptoms suggesting a non–ST-segment elevation myocardial infarction and was transferred to a tertiary medical center for a cardiac catheterization. In patients with uncontrolled hypertension and no evidence of acute coronary syndrome, physicians should keep this rare condition in mind.
J Osteopath Med; 117(8): 537-540

Cardiovascular Disease Risk Factors After an Employer Based Risk Reduction Program: An Observational Cohort Study

David H. Holben, PhD, RDN, LD; Chelsea Rambo, MS, RDN, LD; Cheryl Howe, PhD, CES; Deborah H. Murray, MS, RDN, LD; and Jay H. Shubrook, DO
To determine the effectiveness of a comprehensive lifestyle intervention program that integrated dietary modification, physical activity, stress management, and behavior modification counseling to reduce the risk of CVD in at risk adults, the authors recruited 97 participants to 1 year cohorts that participated in a comprehensive employer sponsored lifestyle intervention program at a rural university in Appalachian Ohio were studied.
J Osteopath Med; 117(7): 425-432

A Stepwise Approach to the Management of Heart Failure and its Comorbidities

Felix J. Rogers, DO, and Zeinab Saghir, DO
The authors propose a practical and straightforward 2-step approach to manage heart failure with reduced ejection fraction and heart failure comorbidities. Their proposed approach aims to reduce cardiac mortality and hospitalization.
J Osteopath Med; 120(2): 90-99

Daily Integrated Care Conferences to Reduce Length of Hospital Stay for Patients With Chronic Obstructive Pulmonary Disease

Ryan Shilian, DO; Tina Abraham, DO; Jonathan Wynbrandt, MD; Devi Jhaveri, DO; Robert W. Hostoffer, DO, LhD, MSMEd; and Brian P. Peppers, DO, PhD
Length of hospital stays can be increased because of lack of effective communication and care coordination among multiple health care professionals. To provide more efficient care, researchers investigate the use of daily integrated care conferences.
J Osteopath Med; 120(3): 144-152

Antithrombotic Therapy for Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention

Andrew S. Tseng, MD; Fadi E. Shamoun, MD; Lisa A. Marks, MLS; and Neera Agrwal, MD, PhD
Antithrombotic therapy regimens that include both oral anticoagulant and antiplatelet agents are prescribed for a variety of indications. The authors examine the US and European guidelines for AF and the trials on which they are based.
J Osteopath Med; 120(5): 345-349